Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

“Love What You Do” is on a sign in Libby’s office for good reason: she loves her work as a dynamic public policy advocate, lawyer, strategist and facilitator. Clients hire her to delve deep in the issues, devise a strategy and execute on many fronts. Libby works primarily on policies and issues confronting health and technology stakeholders, but she also touches the insurance industry. She has built trusted relationships with U.S. and international government agencies, law enforcement, and policymakers on both sides of the aisle. Libby serves on the firm’s board, which sets the firm’s direction, strategy and policy.

Much of Libby’s work relates to digital health — the intersection of internet, technology and health, including:

  • Internet/ online pharmacies
  • Pharmacy compliance and regulatory strategy
  • Telemedicine / telehealth
  • Compound pharmacy compliance – 503(A) and 503(B)
  • Cannabinoid policy
  • Opioid and substance use disorder issues online, including the Ryan Haight Act
  • Pharmaceutical supply chain security and integrity, including the Drug Supply Chain Security Act
  • Counterfeit, falsified and substandard medicines
  • Food and Drug Administration (FDA) regulations and public policy
  • International regulatory harmonization and capacity building 

Libby is proud to represent a number of national organizations and coalitions on a variety of issues, including (but not limited to) the:

  • Alliance for Safe Online Pharmacies (ASOP Global)
  • ASOP Global Foundation
  • American Telemedicine Association (ATA)
  • ATA Action
  • Medical Transportation Access Coalition
  • National Association of Boards of Pharmacy (NABP)
  • Wholesale and Specialty Insurance Association (WSIA)

International Digital Health Consulting

Due to the internet’s broad reach, public health, patient safety and compliance with the rule of law are inherently global — and so is Libby's work. Libby counsels clients on issues involving governments and private sector stakeholders in the European Union, India, Canada, Asia and Latin America. She participates in global Internet Corporation for Assigned Names and Numbers (ICANN) meetings and working groups, engages in various forums within the Asia-Pacific Economic Cooperation's Regulatory Harmonization Steering Committee (RHSC), and often collaborates with other multilateral organizations.

Libby serves clients of Faegre Drinker Consulting as a consulting professional, and does not act as a lawyer for those clients. Separately, Libby serves other clients as a lawyer for Faegre Drinker Biddle & Reath LLP. She can help you decide which services are best for you. Learn more.

Legal Design

Libby uses her problem-solving skills to aid in the firm’s work with DesignLab, offering Design Sprints, workshops and applied design thinking to advance solutions. As a Design Lab Ambassador in D.C., she applies design thinking to client projects aimed at influencing the government and stakeholders through well-designed dashboards illustrating complex policy issues.

Personal Interests

An avid athlete, Libby enjoys regular morning workouts, the occasional round of golf, and cycling to and from Washington, D.C. In her spare time, she can be found playing with her son, catching up on TEDTalks podcasts or scuba diving.

Insights & Events

Other Perspectives
  • Drug dealers use fake online pharmacies and search engine loopholes to sell on Google
    Washington Examiner, October 2024
  • Navigating FDA Supply Rule Leeway For Small Dispensers
    Law360, July 2024
  • Drug shortage raises concerns over potential fake pharmaceuticals
    IPRC Connections, Intellectual Property Rights Coordination Center, January 2023
  • Recent and Anticipated Federal and State Policy Efforts
    Speaker, Rx-360 Supply Chain Security Steering Committee Meeting
  • Consumer Protection and Counterfeits: Public Messaging as a Strategy
    Panelist, Forum on Brand Protection and Anti-Counterfeiting Strategies, June 2019
  • Politics Prompts Problematic Policymaking      
    Innovations, March 2019
  • Trump Administration Reports Highlight Efforts to Combat Illegal Online Drug Sales
    Co-author, .Pharmacy, March 2019
  • Lower Drug Prices Aren’t Worth Higher Health Risks
    Co-author, Drug Topics, March 2019
  • 2019 Illegal Online Pharmacies: The Risks to Patient Health and Brand Reputation
    Co-author, World Trademark Review, March 2019
  • With New Congress Comes Renewed Prescription Drug Importation Efforts at the State, National Levels
    Co-author, .Pharmacy, February 2019
  • Congress Presses Federal Action to Update Remote Prescribing of Controlled Substances Policy
    Co-author, .Pharmacy, January 2019
  • Behavioral Health, the Ryan Haight Act, and Telemedicine
    National Council for Behavioral Health's Annual Policy Forum, October 2017
  • Blue Cross Blue Shield Community Meeting
    White River Junction, VT, October 2017
  • Telehealth: A Priority for Advancing Quality Health Care
    Co-author, Law360, September 2017
  • Pharmaceuticals and Pharmaceutical Benefit Management
    Blue Plan General Counsel Roundtable, Washington D.C. September 2017
  • Online Pharmacies: What You Need to Know to Keep Hoosiers Safe
    Indiana Employers Forum, September 2017
  • DC Today and All the Changes
    Rx-360 2017 Roadshow #1, Deefield, IL, July 2017
  • ASOP Global, CPhA and NABP Roundtable on Canadian Online Pharmacies
    Canadian Pharmacists Association Annual Meeting, June 2017
  • Lessons Learned About U.S. Behavior and Perception of Online Pharmacies
    ASOP EU Forum with EU Member States, June 2017
  • ASOP Global and NABP Roundtable on Canadian Online Pharmacies
    National Association of Boards of Pharmacy Annual Meeting, May 2017
  • Securing Medical Product Quality Through the Supply Chain
    APEC RHSC Regulatory Science Center of Excellence (CoE) for Product Quality & Supply Chain Pilot Program, March 2017
  • India International Forum on Patient Safety and Access to Safe Online Pharmacies
    ASOP Global, U.S. Pharmacopeial Convention and Consumer Online Foundation (India), New Delhi, India, March 2017
  • Protecting Patients in the Digital Health Environment
    U.S. Pharmacopeia Joint Leadership Meeting, February 2017
  • Online Sales of Medications
    Indianapolis Coalition for Patient Safety, February 2017
  • Valuing - and Getting Value From - Millennial Women Lawyers
    National Museum for Women in the Arts, Best Friends at the Bar - Book Launch, Washington D.C., October 2015
  • Developing Public Private Partnerships in the Health Sector
    Guest Lecturer, American University Department of Public Administration and Policy, October 5, 2015
  • The Newest Diversion Tool: Online Pharmacies and Telemedicine
    National Association of State Controlled Substance Authorities (NASCSA) Annual Meeting, Savannah, Georgia, October 22, 2014
  • Bad Actors: The Impact and Enforcement of Illegal iGaming Sites
    Gaming Expo (G2E), Las Vegas, Nevada, September 29, 2014
  • The Impacts of Fake Online Pharmacies on Patient Safety
    Partnership for Safe Medicines' Interchange, Washington, D.C., September 18, 2014
  • Consumer Awareness and Enforcement
    Government Affairs Program, International Trademark Association, Washington, D.C., September 16, 2014
  • Engaging Global Leaders: Protecting Patients From Falsified Medicines Online
    Seminar, Microsoft Office, Brussels, Belgium, July 17, 2014
  • Transatlantic Cooperation on Internet Pharmacies
    Public Meeting, Transatlantic Intellectual Property Rights Working Group, Brussels, Belgium, July 16, 2014
  • Patients Impacted by Supply Chain Dangers, PDA/FDA Pharmaceutical
    Supply Chain Conference, Washington, D.C., June 3, 2014
  • Commercial Use of Domain Names: An Analysis of Multiple Jurisdictions
    White Paper, ICANN Privacy/Proxy Services Accreditation Issues (PPSAI) Working Group, May 2014
  • Internet Drug Sales — Public Awareness, Best Practices and Updates
    Asia-Pacific Economic Cooperation (APEC) Senior Officials Meeting, Qingdao, China, May 5-7, 2014
  • Working Together on Global Solutions to Combat Illegal Online Drug Sellers
    Global Access to Medicines Conference, Johns Hopkins Bloomberg School of Public Health, Baltimore, April 18, 2014
  • Combating Illegal Medicines Online — Safety in Numbers
    Global Forum on Access to Safe Medicine Conference, London, April 4, 2014
  • International Action Against Illegal Internet Drug Sales
    Pre-Conference Workshop, Global Forum on Access to Safe Medicines, London, April 2, 2014

Firm Blog Contributions

  • TCAM Today – uncomplicated, practical, day-to-day advice about how to build, protect or monetize a brand

Leadership & Community

Professional Associations

  • American Society of Pharmacy Law
  • D.C. Bar Association

Civic Activities

  • American Telemedicine Association — Standards and Guidelines Committee Workgroup and Invited Expert Advisor 
  • Asia-Pacific Economic Cooperation (APEC) — Regulatory Harmonization Steering Committee, Internet Sales Working Group
  • Federation of State Medical Boards Expert Working Group on Telemedicine Consultations
  • Indiana University Maurer School of Law (Bloomington) — Law Alumni Board, Executive Committee
  • National Association of Boards of Pharmacy — .pharmacy gTLD Advisory Committee
  • National Association of Governors' Prescription Drug Abuse Policy Academy — Expert Faculty Advisor
  • RESOLVE: National Infertility Association — Public Policy Working Group

Firm Leadership

  • Board Member, 2023-present

Honors

  • Super Lawyers — Rising Star, 2013, 2016-21
  • Faegre Drinker — Pro Bono Honor Roll, 2023
  • The Indiana University Maurer School of Law — Distinguished Service Award, 2021 
  • Law360 — Rising Star (Health Care), 2020
  • Burton Award — Internet Pharmacies: Trends, Opportunities and Risks (The Health Lawyer, June 2019 issue), 2020
  • Washington DC Super Lawyers — 2016-19
  • Indiana University — Luminary, 2015
  • Phi Beta Kappa
  • Herman B Wells Scholar at Indiana University, Bloomington
Awards Methodology
No aspect of these recognitions has been approved by the highest court of any state.